Perioperative outcomes of radical cystectomy following neoadjuvant gemcitabine, cisplatin and atezolizumab

You have accessJournal of UrologyCME1 Apr 2023PD36-08 PERIOPERATIVE OUTCOMES OF RADICAL CYSTECTOMY FOLLOWING NEOADJUVANT GEMCITABINE, CISPLATIN AND ATEZOLIZUMAB Ali Mouzannar, Karissa Whiting, Irina Ostrovnaya, Andrew Katims, Trey Durdin, Zachary Feuer, Michael Lattanzi, Hikmat Al-Ahmadie, Colleen Quinlan, Min Teo, David Aggen, Hong Truong, Jeffrey Kamradt, Maged Khalil, Bradley Lash, Ashley Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Yuanquan Yang, Kamal Pohar, Harry Herr, Sherri Donat, Eugene Pietzak, Eugene Cha, Timothy Donahue, William Huang, Dean Bajorin, Gopakumar Iyer, Bernard Bochner, Amir Mortazavi, Arjun Balar, Jonathan Rosenberg, Samuel Funt, and Alvin Goh Ali MouzannarAli Mouzannar More articles by this author , Karissa WhitingKarissa Whiting More articles by this author , Irina OstrovnayaIrina Ostrovnaya More articles by this author , Andrew KatimsAndrew Katims More articles by this author , Trey DurdinTrey Durdin More articles by this author , Zachary FeuerZachary Feuer More articles by this author , Michael LattanziMichael Lattanzi More articles by this author , Hikmat Al-AhmadieHikmat Al-Ahmadie More articles by this author , Colleen QuinlanColleen Quinlan More articles by this author , Min TeoMin Teo More articles by this author , David AggenDavid Aggen More articles by this author , Hong TruongHong Truong More articles by this author , Jeffrey KamradtJeffrey Kamradt More articles by this author , Maged KhalilMaged Khalil More articles by this author , Bradley LashBradley Lash More articles by this author , Ashley RegazziAshley Regazzi More articles by this author , Marwah JihadMarwah Jihad More articles by this author , Neha RatnaNeha Ratna More articles by this author , Abigail BoswellAbigail Boswell More articles by this author , Yuanquan YangYuanquan Yang More articles by this author , Kamal PoharKamal Pohar More articles by this author , Harry HerrHarry Herr More articles by this author , Sherri DonatSherri Donat More articles by this author , Eugene PietzakEugene Pietzak More articles by this author , Eugene ChaEugene Cha More articles by this author , Timothy DonahueTimothy Donahue More articles by this author , William HuangWilliam Huang More articles by this author , Dean BajorinDean Bajorin More articles by this author , Gopakumar IyerGopakumar Iyer More articles by this author , Bernard BochnerBernard Bochner More articles by this author , Amir MortazaviAmir Mortazavi More articles by this author , Arjun BalarArjun Balar More articles by this author , Jonathan RosenbergJonathan Rosenberg More articles by this author , Samuel FuntSamuel Funt More articles by this author , and Alvin GohAlvin Goh More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003334.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Safety and efficacy were reported in the multicenter phase II trial of neoadjuvant gemcitabine, cisplatin (GC), and atezolizumab (A) therapy in patients with muscle-invasive bladder cancer (MIBC) (Funt et al., JCO 2022). Adding A to GC resulted in a 69% downstaging of MIBC (更多